Reference drugs for triple combination test drug in Russia [Design Issues]

posted by PharmCat  – Russia, 2019-11-16 18:22 (2417 d 21:40 ago) – Posting: # 20812
Views: 11,818

❝ Generic companies did develop almost all attractive double combinations for cardiovasulcar diseases and were trying to expand to triple combinations.


And all this at the moment is a offense against the law.

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,571 registered users;
269 visitors (0 registered, 269 guests [including 15 identified bots]).
Forum time: 17:02 CEST (Europe/Vienna)

It requires a very unusual mind
to undertake the analysis of the obvious.    Alfred North Whitehead

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5